Phase 3 Oesophageal Cancer Trial, Recruiting NCT04138212 Sponsor: Henan Cancer Hospital Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Phase 3 Oesophageal Cancer Trial, Recruiting

NCT04138212
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People diagnosed with squamous cell carcinoma (a specific type of cancer) in the part of the oesophagus (food pipe) that runs through the chest, at certain stages of disease spread as classified by their medical team using the 8th TNM staging system
  • People whose cancer has not spread to the lymph nodes in the neck area
  • People who have not yet received any treatment for their cancer
  • People who are considered medically suitable to undergo surgery to remove part of the oesophagus
  • People who are considered medically suitable to receive chemotherapy or a combination of chemotherapy and radiation therapy
  • People with a performance status score of 0 or 1, meaning they are fully active or have only minor restrictions in physical activity (confirm with trial site)
  • People who have provided written consent to participate

Who may not be able to join:

  • People who have previously received treatment for any cancer
  • People who currently have another cancer elsewhere in the body
  • People whose tumour measures 8 cm or more in length
  • People whose tumour measures 5 cm or more in width
  • People who require ongoing steroid medication
  • People who have had a heart attack within the past 6 months
  • People with a diagnosed psychotic condition
  • People whose cancer is not able to be fully removed by surgery
  • People for whom the stomach cannot be used to rebuild the food pipe after surgery
  • People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +8615188301091

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Henan Cancer Hospital
Registry
ClinicalTrials.gov
Start date
22 October 2019
Est. completion
21 December 2023

Where this trial is recruiting

🇨🇳 China

Primary endpoints

overall survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov